Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8740932 | Journal of Microbiology, Immunology and Infection | 2018 | 9 Pages |
Abstract
Levofloxacin prophylaxis in HSCT recipients is associated with the emergence of fluoroquinolone-resistant Gram-negative bacteria. The risk factors and clinical outcomes of bacteremia differ between allo- and auto-HSCT recipients, and these differences should be taken into account when designing strategies to prevent bacteremia.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ching-Hsun Wang, Feng-Yee Chang, Tsu-Yi Chao, Woei-Yau Kao, Ching-Liang Ho, Yeu-Chin Chen, Ming-Shen Dai, Ping-Ying Chang, Yi-Ying Wu, Jung-Chung Lin,